Biomarkers can help a treatment team to determine the best treatment for a patient, see how the patient is responding, and assist in creating a care plan. New tumor markers are being identified with more frequency, so all tumor markers may not yet be reflected on this list.
Immunohistochemical
- KIT (CD117)
- DOG1 (ANO1)
- SDHB
- SDHA
- Molecular (KIT, PDGFRA, BRAF, SDHA/B/C/D, or NF1 mutational analysis)
- 5 + PDGFRA
- BRAF
- ROR2
- SETD2
- SDHA/B/C/D
- NF1
- Whole tissue section
- KIT
- Exons Assessed
- Exon 9
- Exon 11
- Exon 13
- Exon 14
- Exon 17
- PDGFRA Mutational Analysis + Exons
- Exon 12
- Exon 14
- Exon 18
- SDH A/B/C/D
- Programmed death ligand 1 (PD-L1)